Roche succeeds in mid-stage trial for obesity drug developed with Zealand
Source: SeekingAlpha
2026-03-05 14:13:20 ET
More on Roche Holding, Zealand Pharma
- Zealand Pharma A/S 2025 Q4 - Results - Earnings Call Presentation
- Zealand Pharma A/S (ZLDPF) Q4 2025 Earnings Call Transcript
- Roche Holding AG (RHHBY) Shareholder/Analyst Presentation
- Roche CEO Schinecker wants a bite of the weight loss drugs market
- ClearBridge International Growth ACWI Ex-US Strategy adds and exits multiple positions
Read the full article on Seeking Alpha
For further details see:
Roche succeeds in mid-stage trial for obesity drug developed with Zealand
Roche Holding Ltd
NASDAQ: RHHBF
RHHBF Trading
-6.23% G/L:
$436.044 Last:
31 Volume:
$411.36 Open:
RHHBF Latest News
RHHBF Stock Data
$362,551,633,888
800,578,845
N/A
474
N/A
Pharmaceuticals
Healthcare
CH
Basel Switzerland
